Sponsor pipeline

Nykode Therapeutics ASA clinical trial pipeline

Get alerts when Nykode Therapeutics ASA's trials change

1 active trials 1 recruiting 1 disease areas 5 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days

2026-08-27
Primary completion pushed: 2027-09 → 2029-01
Primary endpoint(s) modified
Enrollment increased: 51 → 110 participants
Trial sites reduced: 17 → 12 locations
Completion pushed: 2028-01 → 2030-12
NCT06016920 Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell… · Phase 1/2

Active trials by phase

Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06016920 Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell… HPV Positive Oropharyngeal Squamous Cell Carcinoma Recruiting 2026-08-26

Disease areas by active trials

Head & Neck Cancer (1)

Get alerts when Nykode Therapeutics ASA's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free